3
Total investments
1
Early stage
2
Mid stage
0
Late stage
4y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2025
Shopeaks is revolutionizing social commerce by transforming every media interaction into a direct sales opportunity.
Our customers have seen up to 5x higher Conversion Rate and more than 30% increase in average order value.
Book a demo -> https://calendly.com/daniela-shopeaks/book-a-demo
Leveraging advanced AI, Shopeaks bridges the gap between social engagement and online retail, enabling brands to analyze social media videos, identify products, and create seamless, shoppable, personalized experiences that boost conversion rates from clicks to purchases. With their fingerprint identity technology powered by unique ML algorithms, Shopeaks provides precise, personalized product recommendations and advertising monetization solutions, helping retail brands transform their social channels into high-converting sales platforms. This approach enhances engagement, drives conversions, and delivers unique shopping journeys for customers.
Investor
2024
At Pery, we believe better care starts with better engagement - and better engagement starts with data.
Pery is an AI-powered Patient Data Platform that helps behavioral health clinics and systems reduce no-shows, increase billable sessions, and support care teams without adding more admin work.
We unify data from your existing systems and combine it with real-time patient input through a mobile app. Our AI turns it into risk alerts, care recommendations, and automated follow-ups - all within your current workflow.
Built for behavioral health. Proven to drive results.
Investor
2022
TruLeaf Medical, a medical device startup company, is presenting a breakthrough solution for mitral valve replacement.
Founded in 2017, our mission is to bring an ultimately user-friendly, Transfemoral Mitral Valve Replacement (TMVR) solution that will be available for every cardiologist and every Mitral Regurgitation (MR) patient. Our focus is on procedure simplicity, safety and efficacy.
TruLeafs approach will bring the solution for the long-lasting problem in an elegant, original and safe way.
_____________________
What is MR?
Mitral regurgitation (MR) is a condition in which the valve doesnt close properly. Blood leaks back into the left atrium, decreasing blood flow to the body and causing the left atrial pressure to rise.
What is TMVR?
Transcatheter Mitral Valve Replacement (TMVR) is a cardiac intervention method in which the dysfunctional mitral valve is replaced by a prosthetic valve, using a catheter-based approach.
_____________________
More updates are coming in the near future. Follow us and visit our website to learn more!
Experience · 5 entries
All (5)
Investments (3)
Founder (2)
2025
Investor
Feb 2025
Shopeaks is revolutionizing social commerce by transforming every media interaction into a direct sales opportunity.
Our customers have seen up to 5x higher Conversion Rate and more than 30% increase in average order value.
Book a demo -> https://calendly.com/daniela-shopeaks/book-a-demo
Leveraging advanced AI, Shopeaks bridges the gap between social engagement and online retail, enabling brands to analyze social media videos, identify products, and create seamless, shoppable, personalized experiences that boost conversion rates from clicks to purchases. With their fingerprint identity technology powered by unique ML algorithms, Shopeaks provides precise, personalized product recommendations and advertising monetization solutions, helping retail brands transform their social channels into high-converting sales platforms. This approach enhances engagement, drives conversions, and delivers unique shopping journeys for customers.
2024
Investor
2024
At Pery, we believe better care starts with better engagement - and better engagement starts with data.
Pery is an AI-powered Patient Data Platform that helps behavioral health clinics and systems reduce no-shows, increase billable sessions, and support care teams without adding more admin work.
We unify data from your existing systems and combine it with real-time patient input through a mobile app. Our AI turns it into risk alerts, care recommendations, and automated follow-ups - all within your current workflow.
Built for behavioral health. Proven to drive results.
2022
Investor
2022
TruLeaf Medical, a medical device startup company, is presenting a breakthrough solution for mitral valve replacement.
Founded in 2017, our mission is to bring an ultimately user-friendly, Transfemoral Mitral Valve Replacement (TMVR) solution that will be available for every cardiologist and every Mitral Regurgitation (MR) patient. Our focus is on procedure simplicity, safety and efficacy.
TruLeafs approach will bring the solution for the long-lasting problem in an elegant, original and safe way.
_____________________
What is MR?
Mitral regurgitation (MR) is a condition in which the valve doesnt close properly. Blood leaks back into the left atrium, decreasing blood flow to the body and causing the left atrial pressure to rise.
What is TMVR?
Transcatheter Mitral Valve Replacement (TMVR) is a cardiac intervention method in which the dysfunctional mitral valve is replaced by a prosthetic valve, using a catheter-based approach.
_____________________
More updates are coming in the near future. Follow us and visit our website to learn more!
2011
Co-Founder & CEO
2011
Oraki (formerly Total Media Solutions) is an Irish publisher technology company founded in 2005, specialising in programmatic advertising, revenue management, and Google Ad Manager 360 reselling. As one of only nine Google Ad Manager 360 Resellers globally, Oraki provides digital publishers with enterprise-grade infrastructure and monetisation expertise. The company serves publishers collectively reaching over 200 million monthly unique visitors across Europe, the Middle East and Africa. Core capabilities include Google Ad Manager 360 reselling, header bidding, AdX management, Trust & Safety and Core Web Vitals optimisation. Oraki is headquartered in Ireland with offices in London, Tel Aviv and Istanbul.
2009
Investment activity
2022–2025 · 3 investments
Recent (last 2 years)Earlier
